BEAM

Beam Therapeutics Inc.

NasdaqAdd to watchlist

Healthcare · Biotechnology

$25.18

−$1.65−6.17%

Delayed · 2026-09-09T20:00:00.000Z · marketstack

3 of 47tracked managers hold this· Q2 2026

Aug 10, 2026$25.18

−$2.11−7.72%over 1M

Day range4% of range

$25.11$26.70

Session

Previous close: $26.83
Open: $26.70
Volume: 2.85M
Avg volume: -
Day high: $26.70
Day low: $25.11

Fundamentals

Visualize fundamentals and more

Market cap: 2.63B
P/E ratio: -
EPS (TTM): -$0.83
Dividend yield: -
Beta: 2.23
Shares outstanding: 104.33M

Source SEC EDGAR · 9/10/2026

Tracked investors

As of Q2 2026 · 72 days ago · next update ~14 Nov 2026· what moved this quarter, onMeasure

3 fund managers this platform follows disclosed a position here, from quarterly SEC filings up to 45 days old; a manager may have sold since without yet having to say so.

Baillie Gifford
Baillie Gifford & Co
$10.78M
0.01%of book
Stanley Druckenmiller
Duquesne Family Office
$5.27M
0.12%of book

1 more holder, included withMeasure

Manager	Position	Share of their book	Last change
Baillie Gifford Baillie Gifford & Co	$10.78M	0.01%
Stanley Druckenmiller Duquesne Family Office	$5.27M	0.12%

1 more holder, included withMeasure

Share price, with each quarter a tracked manager’s position changed shaded across the range it traded in.

162432

now

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Q3 '25

Q4 '25

Q1 '26

Q2 '26

Hover a shaded quarter to see it moved. Who, and the range they traded in, is onBespoke

13F filings cover US-listed shares only (not cash, bonds, shorts, or private holdings) and are never a recommendation to do the same.

Risk factors, year on year

Item 1AFebruary 2026 10-KFebruary 2025as filed.

added: 24
dropped: 18
re-drafted: 26

Out of 302 passages in this year’s Item 1A.

New this year

There is also a risk that due to regulatory changes or other unforeseen reasons, our existing net operating losses or business tax credits could expire or otherwise become unavailable to offset future income tax liabilities. At the state level, there may also …

41 more passages, included withBespoke

Recent activity

Jul 27Simon Amy sold 16,667 sharesInsider tradingForm 4Chief Medical Officer, about $429k, pre-planned (10b5-1)
Jun 30Stanley Druckenmiller opened a position in BEAMTracked manager13Fas of the quarter ended 2026-06-30
Jun 30Joel Greenblatt opened a position in BEAMTracked manager13Fas of the quarter ended 2026-06-30

5 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like Beam Therapeutics Inc.

Also filed under Biotechnology, ranked by how closely they sit beside BEAM.

MRNAModerna, Inc.
ALNYALNYLAM PHARMACEUTICALS, INC.
REGNREGENERON PHARMACEUTICALS, INC.
VRTXVERTEX PHARMACEUTICALS INC / MA
INSMINSMED Inc
ARGXARGENX SE

Ask about Beam Therapeutics Inc.

The assistant answers from what BEAM has actually filed: 7 annual reports filed with the SEC, 54 Form 4 filings from the last year, 13F positions from the 3 tracked investors who hold it and 6 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from BEAM's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding Beam Therapeutics Inc., and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with Beam Therapeutics Inc.

Separate the decisions from the paperwork
Every Form 4 BEAM insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about Beam Therapeutics Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.